Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amlodipine for correction of elevated uterine artery pulsatility index during hormone replacement therapy for frozen embryo transfer
2021-001399-40Phase 4Terminated
- Sponsor
- CHU Montpellier
- Start
- Apr 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in infertility comparing Amlodipine + hormone replacement therapy with Placebo + hormone replacement therapy (2 arms). Primary endpoint: Normalization of uterine artery pulsatility index. Started Apr 2021; status: terminated.
02
Drugs
amlodipine
03
Conditions
infertility
Beyond the preview
Go deeper on 2021-001399-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-001399-40.